Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prestige Consumer Healthcare (PBH) Return on Sales (2016 - 2025)

Prestige Consumer Healthcare has reported Return on Sales over the past 16 years, most recently at 0.16% for Q4 2025.

  • Quarterly results put Return on Sales at 0.16% for Q4 2025, down 5.0% from a year ago — trailing twelve months through Dec 2025 was 0.17% (down 2.0% YoY), and the annual figure for FY2025 was 0.19%, changed 0.0%.
  • Return on Sales for Q4 2025 was 0.16% at Prestige Consumer Healthcare, up from 0.15% in the prior quarter.
  • Over the last five years, Return on Sales for PBH hit a ceiling of 0.21% in Q2 2021 and a floor of 0.84% in Q1 2023.
  • Median Return on Sales over the past 5 years was 0.19% (2024), compared with a mean of 0.13%.
  • Biggest five-year swings in Return on Sales: plummeted -104bps in 2023 and later surged 102bps in 2024.
  • Prestige Consumer Healthcare's Return on Sales stood at 0.18% in 2021, then rose by 3bps to 0.19% in 2022, then decreased by 0bps to 0.19% in 2023, then rose by 12bps to 0.21% in 2024, then dropped by -22bps to 0.16% in 2025.
  • The last three reported values for Return on Sales were 0.16% (Q4 2025), 0.15% (Q3 2025), and 0.19% (Q2 2025) per Business Quant data.